CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Virtual Healthcare Conference at 9:40 a.m. ET on Tuesday, May 12, 2020.
CONMED Corporation (NYSE: CNMD) today announced that Mark E. Tryniski, Chair of the Board, has notified the Company that he will not stand for reappointment to the Chair position in May 2020, although he will stand for reelection as a director. The Board has appointed Curt R. Hartman to succeed Mr. Tryniski and serve as Chair, in addition to his role as Chief Executive Officer, effective immediately following the 2020 Annual Shareholder Meeting.
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter of 2020 after the market close on Wednesday, April 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Q1 2020 Conmed Corp Earnings Call
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2020 to all shareholders of record as of June 15, 2020.
CONMED Corporation (NYSE: CNMD) today announced updated revenue expectations for the first quarter of 2020 to reflect the anticipated impact of the COVID-19 (Coronavirus) outbreak on its global business.
CONMED Corporation (NYSE: CNMD) today announced that the 2020 Annual Meeting of Shareholders will be held on May 21, 2020 at 1:30 p.m. ET. Shareholders as of the close of business on the record date, April 3, 2020, will be eligible to attend, vote at, and participate in the Annual Meeting.
Today we will run through one way of estimating the intrinsic value of CONMED Corporation (NYSE:CNMD) by projecting...
CONMED's (CNMD) first-quarter results gain from strong performance in General Surgery segment and expansion in margins.
CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D. However, forex remains a woe.
CONMED Corporation (NYSE: CNMD) today announced that its 2020 Annual Meeting of Shareholders, scheduled for May 21, 2020, at 1:30 p.m. ET, will be hosted as a virtual-only meeting due to public health concerns and social-distancing restrictions imposed by governmental authorities with respect to non-essential gatherings arising from the COVID-19 pandemic.
The coronavirus pandemic likely to disrupt the first-quarter performances of players in the MedTech space.
MMSI vs. CNMD: Which Stock Is the Better Value Option?
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medical technology company Conmed Corp. issued a revenue warning for the first quarter on Tuesday to reflect the impact on its business of the coronavirus that causes COVID-19. The Utica, New York-based company said it now expects revenue to grow 2% to 4% in the quarter, down from prior guidance of growth of 5% to 6%. Per-share earnings are expected to grow in the mid-single digits, compared with prior guidance for high-single digit to low double-digit growth. The company offered the new guidance ahead of a healthcare conference and said it will not update its 2020 outlook for now. Shares were not yet active premarket, but have gained 6% in the last 12 months, while the S&P 500 has gained 0.1%.
CONMED Corporation (NYSE: CNMD) today announced an amendment to its existing credit agreement, including adjustments to, and suspension of, certain debt covenant thresholds. The terms of the amended agreement are temporary in nature and were granted to provide the Company with financial assurance and flexibility as it navigates the COVID-19 pandemic.
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2020.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Conmed (CNMD) delivered earnings and revenue surprises of 15.91% and 2.60%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
To the annoyance of some shareholders, CONMED (NYSE:CNMD) shares are down a considerable 54% in the last month. That...